Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

UK Investor Show - Saturday 5 April

28th Mar 2014 16:16

RNS Number : 5025D
Orogen Gold PLC
28 March 2014
 



 

Orogen Gold plc

 

UK Investor Show 2014 - Saturday 5 April, London

Orogen Gold plc (AIM:ORE) (the "Company"), the AIM quoted gold exploration company, informs shareholders that it has taken a stall at the UK Investor Show 2014, being held on Saturday 5 April, at the QEII Conference Centre, London.

The Company will be positioned at Stall W23.

Chief Executive Ed Slowey and other members of the Board look forward to meeting any shareholders that are interested to attend.

Please see the following link for the event details and registration.

http://www.ukinvestorshow.com/

 

Enquiries:

 

Orogen Gold Plc

+353 1662 8395

Ed Slowey, CEO

Alan Mooney, FD

WH Ireland Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7220 1666

Tim Feather

James Bavister

Hume Capital Securities Plc (Joint Broker)

Jon Belliss

Walbrook (Public Relations and Investor Relations)

+44 (0) 20 3693 1470

+44 (0) 20 933 8780

Paul Cornelius/ Bob Huxford/Guy McDougall

 

 

About Orogen Gold

Orogen Gold plc is a UK public company quoted on the London Stock Exchange AIM market (ticker: ORE). The Company is focused on mineral exploration and development in Europe and is currently running two gold exploration projects: a) at Mutsk in Armenia and b) at Deli Jovan in Serbia. The Mutsk gold project in Armenia was optioned by Orogen early in 2013 to follow-up reports of a new epithermal discovery within an established gold district. At Deli Jovan the historic high-grade gold mining camp was last in production prior to World War II and has been significantly under-explored in modern times.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUWANRSSAOUAR

Related Shares:

Sosandar
FTSE 100 Latest
Value8,809.74
Change53.53